- GROUP Rare Cancers
- FUNDING 123
- PROJECT SPAN 2022
- DATE 02/05/2022
Overview
The AGCMC is a national network of eight cancers centres – one centre in every state and territory in Australia – that delivers the Australian Genomics Cancer Medicine Program.
Details on this project
The program oversees precision oncology clinical trials and screening studies including: the Molecular Screening and Therapeutics (MoST) study; Genic Cancer Risk in the Young (RisC) study; and Surveillance study in Multi-Organ prone syndromes (SMOC+).
The primary AGCMC centres are:
- Canberra Hospital, ACT
- The Kinghorn Cancer Centre/Garvan Institute, NSW
- Peter MacCallum Cancer Centre, VIC
- Prince Alexandra Hospital, QLD
- Royal Adelaide Hospital, SA
- Royal Darwin Hospital, NT
- Royal Hobart Hospital, TAS
- Sir Charles Gairdner Hospital, WA
The MoST study performs genomic profiling to analyse the molecular characteristics of a patient’s tumour, and where possible, match them to a MoST therapeutic study (clinical trial) or other targeted therapy. Suitable patients include those aged 16 years and older with an advanced and/or metastatic sold or blood cancer with limited treatment options, and who are fit enough and willing to participate in a clinical trial. The study is targeting rare and less common cancers.
For more information visit omico.com.au
Let me know if you want to use this space
Can use this for as many items as you like
Related projects
Rare Cancers
The Australian Rare Cancer (ARC) Portal
Rare Cancers
The Stafford Fox Rare Cancer Program (SFRCP)
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow

COSAoncology 11 hours ago
🚨 Submit your #COSA22 abstract TODAY 🚨 Need a deadline to work to? Here it is! #COSA22 abstract submissions close MIDNIGHT AEST tonight!Last chance to finalise & submit ➡️ https://t.co/Pr91BEYqHH pic.twitter.com/OLsoPloe4P
Read More >
COSAoncology 23 hours ago
COSA members can make an impact on cancer control by subscribing to as many COSA Groups as they like! 🤝 Collaborate with COSA's multidisciplinary membership and contribute to Group activities.🖱️ Log in and update your preferences: https://t.co/WdMufywsoR pic.twitter.com/NLyeUlDJPU
Read More >
COSAoncology yesterday
We're looking for a proactive people person to enhance COSA member engagement & experience.The Membership Officer role is a part-time, flexible, 12 mth contract (with potential to renew). Contact us with Qs or apply now. Pls share with your networks! https://t.co/SMnzfElU80 pic.twitter.com/NZSTa5QtJA
Read More >
COSAoncology yesterday
Attention NSW and ACT researchers: expressions for the Enduring Cancer Data Linkage (CanDLe) program are now open. Details and applications: https://t.co/A1nLvVfQ0P pic.twitter.com/e6xKH2pUnn
Read More >
COSAoncology 2 days ago
With >30 #cancer #nurse leaders & our member organisations, our @ISNCC team has developed an international competency framework re. self-management support for ppl with cancer. —> https://t.co/3IiDfob6p7@CNSA_ORG @oncologynursing @CanoResearch #SelfMangement #survonc #supponc pic.twitter.com/FSjiIVqldp
Read More >
COSAoncology 2 days ago
📣 2 days left to submit your #COSA22 abstract.Finalise your oral & poster presentation abstracts and SUBMIT BY MIDNIGHT AEST THIS FRIDAY 12 AUGUST.We look forward to your innovative & important research.Submit at ➡️ https://t.co/Pr91BEYqHH pic.twitter.com/qIrq4ZDVOh
Read More >
COSAoncology 3 days ago
Cancer Australia welcomes the launch of 8 new Optimal Care Pathways (OCPs) for blood cancer. OCPs set national standards of blood cancer treatment and care. Find out more at https://t.co/hwmKxowvst #BloodCancer @LeukaemiaAus pic.twitter.com/BSmG21ENoz
Read More >
COSAoncology 3 days ago
💻 Our guidelines for fertility preservation for people with #cancer are live! 👶 Designed by HPs, for HPs, these guidelines will assist in discussing & managing fertility preservation for children, adolescents & adults of reproductive age @thewomens @ANZoncofert pic.twitter.com/oRkjkISLKc
Read More >
COSAoncology 3 days ago
Registrations are open for the @TOGAANZ 2022 Lung Cancer PreceptorshipAn active learning 2-day workshop 4 medical trainees & fellows to develop clinical knowledge & expertise in thoracic cancer mgmt & engage w mentors https://t.co/l8KHDxODex#LCSM pic.twitter.com/j8vmPpnOgF
Read More >
COSAoncology 4 days ago
AOMA Summit 2022 videos are now available to watch on the MASC Trials YouTube Channel. Featuring international and Australian experts in ocular melanoma as well as consumers.📺 https://t.co/cxbIK7d5Ga#Ocular #Uveal #Melanoma #AOMA22 #EyeCancer@AnthonyMJoshua @DrDamienKee pic.twitter.com/MD64Q1Bx7Q
Read More >